Crescent Biopharma, Inc. Common Stock (NASDAQ: CBIO) last traded at $17.15, up 5.67% on the session. The quote above updates while this page is open; the figures below are drawn from Crescent Biopharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
Crescent Biopharma, Inc. Common Stock trades on NASDAQ under the ticker CBIO. Its market capitalisation is $637.02 million.
Valuation measures for Crescent Biopharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $637.02M |
|---|---|
| Enterprise value | $484.93M |
| Price / sales | 58.74 |
| Price / book | 3.90 |
| Beta | 0.82 |
Trailing-twelve-month figures tagged in Crescent Biopharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $10.84M |
|---|---|
| Net income (TTM) | -$96.03M |
| Operating margin | -1553.59% |
| Return on equity | -58.82% |
| Cash | $171.59M |
Range and volume for CBIO over the past 52 weeks.
| 52-week high | $27.41 |
|---|---|
| 52-week low | $8.72 |
| Volume | 215.6K |
| Average volume | 330.2K |
| Previous close | $16.23 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.